Lp(a) only modestly improved prediction when added to risk estimates, but it still can be used to personalize care.

AbstractAims. Recent aspirin primary prevention trials failed to identify a net benefit of aspirin for preventing cardiovascular disease vs. the harms of b

The new blood test from Roche Diagnostics measures Lp(a) in terms of nanomoles per liter (nmol/L) as opposed to milligrams per deciliter (mg/dL).

This 20-minute episode covers Clinical and more with Doctor E. Joyce (Ireland,IE), Doctor C. Aguiar (Portugal,PT),Doctor H. Jorstad (Netherlands (The),NL),Professor J. Rodriguez Palomares (Spain,ES).

Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease. The relationship between Lp(a) and major adverse card…

Harpreet Bhatia, MD, MAS, FACC, discusses emerging new approaches to lipid lowering therapies.